The critical role of insulin-like growth factor-1 isoforms in the physiopathology of skeletal muscle

Current Genomics

Volumn 7, Issue 1, 2006, Pages 19-32

  Musarò, Antonio ^a,b,d   Rosenthal, N ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b EDITH COWAN UNIVERSITY   (Australia)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

^d Department of Histology and Medical Embryology ^*  (Italy)

Author keywords

Cartilage homeostasis; Cortical neurons; Mechano growth factor; Myofiber; Myosin light chain (MLC); Post translational modification

Indexed keywords

GROWTH HORMONE; ISOPROTEIN; SOMATOMEDIN C;

AGING; AUTOCRINE EFFECT; BIOSYNTHESIS; BREAST CANCER; CELL BASED GENE THERAPY; CELL COUNT; COLON CANCER; HEART; HEART HYPERTROPHY; HORMONE ACTION; HOST CELL; HUMAN; MEDICAL RESEARCH; MUSCLE ATROPHY; MUSCLE DEVELOPMENT; MUSCLE FUNCTION; MUSCLE GROWTH; MUSCLE HYPERTROPHY; MUSCLE MASS; MUSCLE REGENERATION; MUSCLE STRENGTH; MYOBLAST; MYOPATHY; NEOPLASM; NEUROMUSCULAR DISEASE; NONHUMAN; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PATIENT CARE; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RISK REDUCTION; TISSUE SPECIFICITY;

EID: 33746876768     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920206776389784     Document Type: Review

References (121)

1. Stewart, C.E., Rotwein, P. Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol. Rev. 1996, 76: 1005-26.
2. Butler, A.A., LeRoith, D. Minireview: tissue-specific versus generalized gene targeting of the igf1 and igf1r genes and their roles in insulin-like growth factor physiology. Endocrinology 2001, 142: 1685-88.
3. LeRoith, D., Roberts, C.T. Jr. Insulin-like growth factor I (IGF-I): a molecular basis for endocrine versus local action? Mol. Cell. Endocrinol. 1991, 77: C57-61.
4. Adamo, M.L., Ben-Hur. H., Roberts. C.T. Jr., LeRoith, D. Regulation of start site usage in the leader exons of the rat insulin-like growth factor-I gene by development, fasting, and diabetes. Mol. Endocrinol. 1991, 5: 1677-86.
5. LeRoith, D., Roberts, C.T. Jr. Insulin-like growth factors. Ann. N. Y. Acad. Sci. 1993, 692: 1-9.
6. McKoy, G., Ashley, W., Mander, J., Yang, S.Y., Williams, N., Russell, B., Goldspink, G. Expression of insulin growth factor-1 splice variants and structural genes in rabbit skeletal muscle induced by stretch and stimulation. J. Physiol. 1999, 516: 583-92.
7. Bach, M.A., Roberts, C.T. Jr, Smith, E.P., LeRoith, D. Alternative splicing produces messenger RNAs encoding insulin-like growth factor-I prohormones that are differentially glycosylated in vitro. Mol. Endocrinol. 1990, 4: 899-904.
8. Adamo, M.L., Neuenschwander, S., LeRoith, D., Roberts, C.T. Jr. Structure, expression, and regulation of the IGF-I gene. Adv. Exp. Med. Biol. 1993, 343: 1-11.
9. LeRoith, D., Bondy, C., Yakar, S., Liu, J.L., Butler, A. The somatomedin hypothesis: 2001. Endocr. Rev. 2001, 22: 53-74.
10. Liu, J.P., Baker, J., Perkins, A.S., Robertson, E.J., Efstratiadis, A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 1993, 75: 59-72.
11. Powell-Braxton, L., Hollingshead, P., Warburton, C., Dowd, M., Pitts-Meek, S., Dalton, D., Gillett, N., Stewart, T.A. IGF-I is required for normal embryonic growth in mice. Genes Dev. 1993, 7: 2609-17.
12. Florini, J.R., Ewton, D.Z., Coolican, S.A. Growth hormone and the insulin-like growth factor system in myogenesis. Endocr. Rev. 1996, 17: 481-517.
13. Liu, J.L., LeRoith, D. Insulin-like growth factor I is essential for postnatal growth in response to growth hormone. Endocrinology 1999, 140: 5178-84.
14. Ludwig, T., Eggenschwiler, J., Fisher, P., D'Ercole, A.J., Davenport, M.L., Efstratiadis, A. Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev. Biol. 1996, 177: 17-35.
15. Holzenberger, M., Leneuve, P., Hamard, G., Ducos, B., Perin, L., Binoux, M., Le Bouc, Y. A targeted partial invalidation of the insulin-like growth factor I receptor gene in mice causes a postnatal growth deficit. Endocrinology 2000, 141: 2557-66.
16. Dietrich, P., Dragatsis, I., Xuan, S., Zeitlin, S., Efstratiadis, A. Conditional mutagenesis in mice with heat shock promoter-driven cre transgenes. Mamm. Genome 2000, 11:196-205.
17. Liu, J.L., Grinberg, A., Westphal, H., Sauer, B., Accili, D., Karas, M., LeRoith, D. Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: manipulation using the Cre/loxP system in transgenic mice. Mol. Endocrinol. 1998, 12: 452-62.
18. Yakar, S., Liu, J.L., Stannard, B., Butler, A., Accili, D., Sauer, B., LeRoith, D. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc. Natl. Acad. Sci. USA 1999, 96: 7324-9.
19. Shavlakadze, T., Winn, N., Rosenthal, N., Grounds, M.D. Reconciling data from transgenic mice that overexpress IGF-I specifically in skeletal muscle. Growth Horm. IGF Res. 2005, 15: 4-18.
20. Coleman, M.E., DeMayo, F., Yin, K.C., Lee, H.M., Geske, R., Montgomery, C., Schwartz, R.J. Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J. Biol. Chem. 1995, 270: 12109-16.
21. Renganathan, M., Messi, M.L., Schwartz, R., Delbono, O. Overexpression of hIGF-1 exclusively in skeletal muscle increases the number of dihydropyridine receptors in adult transgenic mice. FEBS Lett. 1997, 417: 13-6.
22. Criswell, D.S., Booth, F.W., DeMayo, F., Schwartz, R.J., Gordon, S.E., Fiorotto, M.L. Over-expression of IGF-I in skeletal muscle of transgenic mice does not prevent unloading-induced atrophy. Am. J. Physiol. 1998, 275: E373-9.
23. Musarò, A., McCullagh, K., Paul, A., Houghton, L., Dobrowolny, G., Molinaro, M., Barton, E.R., Sweeney, H.L., Rosenthal, N. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat. Genet. 2001, 27:195-200.
24. Reiss, K., Cheng, W., Ferber, A., Kajstura, J., Li, P., Li, B., Olivetti, G., Homcy, C.J., Baserga, R., Anversa, P. Over-expression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice. Proc. Natl. Acad. Sci. USA 1996, 93: 8630-5.
25. Delaughter, M.C., Taffet, G.E., Fiorotto, M.L., Entman, M.L., Schwartz, R.J. Local insulin-like growth factor I expression induces physiologic, then pathologic, cardiac hypertrophy in transgenic mice. FASEB J. 1999, 13: 1923-9
26. Li, Q., Li, B., Wang, X., Leri, A., Jana, K.P., Liu, Y., Kajstura, J., Baserga, R., Anversa, P. Over-expression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J. Clin. Invest. 1997, 100: 1991-9.
27. Leri, A., Liu, Y., Wang, X., Kajstura, J., Malhotra, A., Meggs, L.G., Anversa P. Over-expression of insulin-like growth factor-1 attenuates the myocyte resin-angiotensin system in transgenic mice. Circ. Res. 1999, 84: 752-62.
28. Li, B., Setoguchi, M., Wang, X., Andreoli, A.M., Leri, A., Malhotra, A., Kajstura, J., Anversa, P. Insulin-like growth factor-1 attenuates the detrimental impact of nonocclusive coronary artery constriction on the heart. Circ. Res. 1999, 84: 1007-19.
29. Kajstura, J., Fiordaliso, F., Andreoli, A.M., Li, B., Chimenti, S., Medow, M.S., Limana, F., Nadal-Ginard B., Leri, A., Anversa, P. IGF-1 over-expression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes 2001, 50: 1414-24.
30. Schulze, P.C., Fang, J., Kassik, K.A., Gannon, J., Cupesi, M., MacGillivray, C., Lee, R.T., Rosenthal, N. Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricular dysfunction. Circ. Res. 2005, 97: 418-26.
31. Lee, K.H., Calikoglu, A.S., Ye, P., D'Ercole, A.J. Insulin-like growth factor-I (IGF-I) ameliorates and IGF binding protein-1 (IGFBP-1) exacerbates the effects of undernutrition on brain growth during early postnatal life: studies in IGF-I and IGFBP-1 transgenic mice. Pediatr. Res. 1999, 45: 331-6.
32. Gao, W.Q., Shinsky, N., Ingle, G., Beck, K., Elias, K.A., Powell-Braxton, L. IGF-I deficient mice show reduced peripheral nerve conduction velocities and decreased axonal diameters and respond to exogenous IGF-I treatment. J. Neurobiol. 1999, 39: 142-52.
33. Dentremont, K,D,, Ye. P,, D'Ercole. A,J., O'Kusky, J.R. Increased insulin-like growth factor-I (IGF-I) expression during early postnatal development differentially increases neuron number and growth in medullary nuclei of the mouse. Brain Res. Dev. Brain Res. 1999, 114: 135-41.
34. O'Kusky, J.R., Ye, P., D'Ercole, A.J. Insulin-like growth factor-I promotes neurogenesis and synaptogenesis in the hippocampal dentate gyrus during postnatal development. J. Neurosci. 2000, 20: 8435-42.
35. Chrysis, D., Calikoglu, A.S., Ye, P., D'Ercole, A.J. Insulin-like growth factor-I over-expression attenuates cerebellar apoptosis by altering the expression of Bcl family proteins in a developmentally specific manner. J. Neurosci. 2001, 21: 1481-9.
36. Tiangco, D.A., Papakonstantinou, K.C., Mullinax, K.A., Terzis, J.K. IGF-I and end-to-side nerve repair: a dose-response study. Reconstr Microsurg. 2001, 17: 247-56.
37. Ye, P., Lee, K.H., D'Ercole, A.J. Insulin-like growth factor-I (IGF-I) protects myelination from undernutritional insult: studies of transgenic mice overexpressing IGF-I in brain. J. Neurosci. Res. 2000, 62: 700-8.
38. Camarero, G., Avendano, C, Fernandez-Moreno, C., Villar, A., Contreras, J., de Pablo, F., Pichel, J.G., Varela-Nieto, I. Delayed inner ear maturation and neuronal loss in postnatal Igf-1-deficient mice. J. Neurosci. 2001, 21: 7630-41.
39. Carro, E., Trejo, J.L., Busiguina, S., Torres-Aleman, I. Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy. J. Neurosci. 2001, 21: 5678-84.
40. Linseman, D.A., Phelps, R.A., Bouchard, R.J., Le, S.S., Laessig, T.A., McClure, M.L., Heidenreich, K.A. Insulin-like growth factor-I blocks Bcl-2 interacting mediator of cell death (Bim) induction and intrinsic death signaling in cerebellar granule neurons. J. Neurosci. 2002, 22: 9287-97.
41. Leinninger, G.M., Backus, C., Uhler, M.D., Lentz, S.I., Feldman, E.L. Phosphatidylinositol 3-kinase and Akt effectors mediate insulin-like growth factor-I neuroprotection in dorsal root ganglia neurons. FASEB J. 2004, 18: 1544-6.
42. Willaime-Morawek, S., Arbez, N., Mariani, J., Brugg, B. IGF-I protects cortical neurons against ceramide-induced apoptosis via activation of the PI-3K/Akt and ERK pathways; is this protection independent of CREB and Bcl-2. Brain Res. Mol. Brain Res. 2005, 142: 97-106.
43. Digicaylioglu, M., Garden, G., Timberlake, S., Fletcher, L., Lipton, S.A. Acute neuroprotective synergy of erythropoietin and insulin-like growth factor I. Proc. Natl. Acad. Sci. USA 2004, 101: 9855-60.
44. Schmidt, M.B., Chen, E.H., Lynch, S.E. A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair. Osteoarthritis Cartilage. 2006 Jan 18 Epub ahead of print.
45. Bol, D.K., Kiguchi, K., Gimenez-Conti, I., Rupp, T., DiGiovanni, J. Over-expression of insulin-like growth factor-1 induces hyperplasia, dermal abnormalities, and spontaneous tumor formation in transgenic mice. Oncogene 1997, 14: 1725-34.
46. Wilker, E., Bol, D., Kiguchi, K., Rupp, T., Beltran, L., DiGiovanni, J. Enhancement of susceptibility to diverse skin tumor promoters by activation of the insulin-like growth factor-1 receptor in the epidermis of transgenic mice. Mol. Carcinog. 1999, 25: 122-31.
47. DiGiovanni, J., Bol, D.K., Wilker, E., Beltran, L., Carbajal, S., Moats, S., Ramirez, A., Jorcano, J., Kiguchi, K. Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion. Cancer Res. 2000, 60: 1561-70.
48. DiGiovanni, J., Kiguchi, K., Frijhoff, A., Wilker, E., Bol, D.K., Beltran, L., Moats, S., Ramirez, A., Jorcano, J., Conti, C. Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice. Proc. Natl. Acad. Sci. USA 2000, 97: 3455-60.
49. Weber, M.M., Fottner, C., Wolf, E. The role of the insulin-like growth factor system in adrenocortical tumourigenesis. Eur. J. Clin. Invest. 2000, 30: 69-75.
50. Dyck, M.K., Ouellet, M., Gagn, M., Petitclerc, D., Sirard, M.A., Pothier, F. Testes-specific transgene expression in insulin-like growth factor-I transgenic mice. Mol. Reprod. Dev. 1999, 54: 32-42.
51. Dyck, M.K., Parlow, A.F., Senechal, J.F., Sirard, M.A., Pothier, F. Ovarian expression of human insulin-like growth factor-I in transgenic mice results in cyst formation. Mol. Reprod. Dev. 2001, 59: 178-85.
52. Vickers, M.H., Ikenasio, B.A., Breier, B.H. IGF-I treatment reduces hyperphagia, obesity, and hypertension in metabolic disorders induced by fetal programming. Endocrinology 2001, 142: 3964-73.
53. Yang, S., Alnaqeeb, M., Simpson, H., Goldspink, G.J. Cloning and characterization of an IGF-1 isoform expressed in skeletal muscle subjected to stretch. Muscle Res. Cell Motil. 1996, 17: 487-95.
54. Donoghue, M., Ernst, H., Wentworth, B., Nadal-Ginard, B., Rosenthal, N. A muscle-specific enhancer is located at the 3′ end of the myosin light-chain 1/3 gene locus. Genes Dev. 1988, 2: 1779-90.
55. Rosen, C.J. Pollak, M. Circulating IGF-I: new perspectives for a new century. Trends Endocrinol. Metab. 1999, 10: 136-141.
56. Grieshammer, U., Sassoon, D., Rosenthal, N. A transgene target for positional regulators marks early rostrocaudal specification of myogenic lineages. Cell 1992, 69: 79-93.
57. Iwanczak, F., Stawarski, A., Potyrala, M., Siedlecka-Dawidko, J., Agrawal, G. S. Early symptoms of Duchenne muscular dystrophy--description of cases of an 18-month-old and an 8-year-old patient. Med. Sci. Monit. 2000, 6: 592-5.
58. Carlson, B.M. Faulkner, J.A. Muscle transplantation between young and old rats: age of host determines recovery. Am. J. Physiol. 1989, 256: C1262-6.
59. Carlson, B.M. Faulkner, J.A. Muscle regeneration in young and old rats: effects of motor nerve transection with and without marcaine treatment. J. Gerontol. A Biol. Sci. Med. Sci. 1998, 53: B52-57.
60. Grounds, M.D. Age-associated changes in the response of skeletal muscle cells to exercise and regeneration. Ann. N. Y. Acad. Sci. 1998, 854: 78-91.
61. Burton-Davis, E.R., Shoturma, D.I., Musarò, A., Rosenthal, N., Sweeney, H.L. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc. Natl. Acad. Sci. USA 1998, 95: 15603-7.
62. Burton-Davis, E.R., Shoturma, D.I., Sweeney, H.L. Contribution of satellite cells to IGF-I induced hypertrophy of skeletal muscle. Acta Phvsiol. Scand. 1999, 167: 301-5.
63. Lee, S., Barton, E.R., Sweeney, H.L., Farrar, R.P. Viral expression of insulin-like growth factor-I enhances muscle hypertrophy in resistance-trained rats. J. Appl. Physiol. 2004, 96: 1097-104.
64. Cossu, G., De Angelis, L., Borello, U., Berarducci, B., Buffa, V., Sonnino, C., Coletta, M., Vivarelli, E., Bouche, M., Lattanzi, L., Tosoni, D., Di Donna, S., Berghella, L., Salvatori, G., Murphy, P., Cusella-De Angelis, M.G., Molinaro, M. Determination, diversification and multipotency of mammalian myogenic cells. Int. J. Dev. Biol. 2000, 44: 699-706.
65. Edmondson, D.G. Olson, E.N. Helix-loop-helix proteins as regulators of muscle-specific transcription. J. Biol. Chem. 1993, 268: 755-58.
66. Sabourin, L.A., Rudnicki, M.A. The molecular regulation of myogenesis. Clin. Genet. 2000, 57: 16-25.
67. Berkes, C.A., Tapscott, S.J. MyoD and the transcriptional control of myogenesis. Semin. Cell Dev. Biol. 2005, 16: 585-95.
68. Sartorelli, V., Caretti, G. Mechanisms underlying the transcriptional regulation of skeletal myogenesis. Curr. Opin. Genet. Dev. 2005, 15: 528-35.
69. Tajbakhsh, S., Borello, U., Vivarelli, E., Kelly, R., Papkoff, J., Duprez, D., Buckingham, M., Cossu, G. Differential activation of Myf5 and MyoD by different Wnts in explants of mouse paraxial mesoderm and the later activation of myogenesis in the absence of Myf5. Development 1998, 125: 4155-62.
70. Pirskanen, A., Kiefer, J.C., Hauschka, S.D. IGFs, insulin, Shh, bFGF, and TGF-beta1 interact synergistically to promote somite myogenesis in vitro. Dev. Biol. 2000, 224: 189-203.
71. Dhoot, G.K., Gustafsson, M.K., Ai, X., Sun, W., Standiford, D.M., Emerson, C.P. Jr. Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase. Science 2001, 293: 1663-6.
72. Cossu, G. Molinaro, M. Cell heterogeneity in the myogenic lineage. Curr. Top. Dev. Biol. 1987, 23: 185-208.
73. Miller, J.B., Everitt, E.A., Smith, T.H., Block, N.E., Dominov, J.A. Cellular and molecular diversity in skeletal muscle development: news from in vitro and in vivo. BioEssay 1993, 15: 191-196.
74. Buonanno, A., Rosenthal, N. Molecular control of muscle diversity and plasticity. Dev. Genet. 1996, 19: 95-107.
75. Florini, J.R., Ewton, D.Z., Falen, S.L., Van Wyk, J.J. Biphasic concentration dependency of the stimulation of myoblast differentiation by somatomedins. Am. J. Physiol. 1986, 250: 771-78.
76. Rosenthal, S.M. Cheng, Z.Q. Opposing early and late effects of insulin-like growth factor I on differentiation and cell cycle regulatory retinoblastoma protein in skeletal myoblasts. Proc. Natl. Acad. Sci. USA 1995, 92: 10307-11.
77. Engert, J.C., Berglund, E.B., Rosenthal, N. Proliferation precedes differentiation in IGF-1-stimulated myogenesis. J. Cell Biol. 1996, 135: 431-40.
78. Kaliman, P., Vinals, F., Testar, X., Palacin, M., Zorzano, A. Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells. J. Biol. Chem. 1996, 271: 19146-51.
79. Coolican, S.A., Samuel, D.S., Ewton, D.Z., McWade, F.J., Florini, J.R. The mitogenic and myogenic actions of Insulin-like growth factors utilize distinct signaling pathways. J. Biol. Chem. 1997, 272: 6653-62.
80. Tureckova, J., Wilson, E.M., Cappalonga, J.L., Rotwein, P. Insulin-like growth factor-mediated muscle differentiation. collaboration between phosphatidylinositol 3-kinase-akt-signaling pathways and myogenin. J. Biol. Chem. 2001, 276: 39264-70.
81. Ewton, D.Z., Roof, S.L., Magri, K.A., McWade, F.J., Florini, J.R. IGF-II is more active than IGF-I in stimulating L6A1 myogenesis: greater mitogenic actions of IGF-I delay differentiation. J. Cell Physiol. 1994, 161: 277-84.
82. Braun, T., Buschhausen-Denker, G., Bober, E., Tannich, E., Arnold H.H. A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. EMBO J. 1989, 8: 701-9.
83. Wright, W.E., Sassoon, D.A., Lin, V.K. Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell 1989, 56: 607-17.
84. Musarò, A. Rosenthal, N. Maturation of the myogenic program is induced by postmitotic expression of insulin-like growth factor I. Mol. Cell Biol. 1999, 19: 3115-24.
85. Lawlor, M.A. Rotwein, P. Coordinate control of muscle cell survival by distinct insulin-like growth factor activated signaling pathways. J. Cell Biol. 2000, 151: 1131-40.
86. Bodine, S.C., Stitt, T.N., Gonzalez, M., Kline, W.O., Stover, G.L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J.C., Glass, D.J., Yancopoulos, G.D. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat. Cell Biol. 2001, 3: 1014-9.
87. Lai, K.M., Gonzalez, M., Poueymirou, W.T., Kline, W.O., Na, E., Zlotchenko, E., Stitt, T.N., Economides, A.N., Yancopoulos, G.D., Glass, D.J. Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy. Mol. Cell. Biol. 2004, 24: 9295-304.
88. Song, Y.H., Godard, M., Li, Y., Richmond, S.R., Rosenthal, N., Delafontaine, P. Insulin-like growth factor I-mediated skeletal muscle hypertrophy is characterized by increased mTOR-p70S6K signaling without increased Akt phosphorylation. J. Investig. Med. 2005, 53: 135-42.
89. McKinsey, T.A., Zhang, C.L., Lu, J., Olson, E.N. Signal-dependent nuclear export of a historic deacetylase regulates muscle differentiation. Nature 2000, 408: 106-11.
90. Lu, J., McKinsey, T.A., Zhang, C.L., Olson, E.N. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol. Cell. 2000, 6: 233-44.
91. Musarò, A., McCullagh, K.J., Naya, F.J., Olson, E.N., Rosenthal, N. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 1999, 400: 581-5.
92. Semsarian, C., Wu, M.J., Ju, Y.K., Marciniec, T., Yeoh, T., Allen, D.G., Harvey, R.P., Graham, R.M. Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway. Nature 1999, 400: 576-81.
93. Friday, B.B., Horsley, V., Pavlath, G.K. Calcineurin activity is required for the initiation of skeletal muscle differentiation. J. Cell Biol. 2000, 149: 657-66.
94. Crabtree, G.R. Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT. Cell 1999, 96: 611-4.
95. Crabtree, G.R. Calcium, calcineurin, and the control of transcription. J. Biol. Chem. 2001, 276: 2313-6.
96. Molkentin, J.D., Lu, J.R., Antos, C.L., Markham, B., Richardson, J., Robbins, J., Grant, S.R., Olson, E.N. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998, 93: 215-28.
97. Chin, E.R., Olson, E.N., Richardson, J.A., Yang, Q., Humphries, C., Shelton, J.M., Wu, H., Zhu, W., Bassel-Duby, R., Williams, R.S. A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev. 1998, 12: 2499-509.
98. Naya, F.J., Mercer, B., Shelton, J., Richardson, J.A., Williams, R.S., Olson, E.N. Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo. J. Biol. Chem. 2000, 275: 4545-8.
99. Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S.H., Goldberg, A.L. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004, 117: 399-412.
100. Musarò, A. Rosenthal, N. Transgenic mouse models of muscle aging. Exp. Gerontol. 1999, 34: 147-56.
101. Eddinger, T.J., Cassens, R.G., Moss, R.L. Mechanical and histochemical characterization of skeletal muscles from senescent rats. Am. J. Physiol. 1986, 251: C421-30.
102. Musaro, A., Cusella De Angelis, M.G., Germani, A., Ciccarelli, C., Molinaro, M., Zani B.M. Enhanced expression of myogenic regulatory genes in aging skeletal muscle. Exp. Cell Res. 1995, 221: 241-8.
103. Booth, F.W., Criswell, D.S. Molecular events underlying skeletal muscle atrophy and the development of effective countermeasures. Int J. Sports Med. 1997, 18: S265-9.
104. Matsuo, M. Oxygen dependency of life-span in the nematode. Comp. Biochem. Physiol. Comp. Physiol. 1993, 105: 653-8.
105. Bruijn, L.I., Miller, T.M., Cleveland, D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci. 2004, 27: 723-49.
106. Bodensteiner, J.B., Engel, A.G. Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibers in 114 biopsies. Neurology 1978, 28: 439-46.
107. Ervasti, J.M., Ohlendieck, K., Kahl, S.D., Gaver, M.G., Campbell, K.P. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 1990, 345: 315-9.
108. Brenman, J.E., Chao, D.S., Xia, H., Aldape, K., Bredt, D.S. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy Cell 1995, 82: 743-52.
109. Chang, W.J., Iannaccone, S.T., Lau, K.S., Masters, B.S., McCabe, T.J., McMillan, K., Padre, R.C., Spencer, M.J., Tidball, J.G., Stull, J.T. Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc. Natl. Acad. Sci. USA 1996, 93: 9142-7.
110. Wehling, M., Spencer, M.J., Tidball, J.G. A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J. Cell Biol. 2001, 155: 123-32.
111. Charge, S.B., Rudnicki, M.A. Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 2004, 84: 209-38.
112. Musaro, A., Giacinti, C., Borsellino, G., Dobrowolny, G., Pelosi, L., Cairns, L., Ottolenghi, S., Cossu, G., Bernardi, G., Battistini, L., Molinaro, M., Rosenthal, N. Stem cell-mediated muscle regeneration is enhanced by local isoform of insulin-like growth factor 1. Proc. Natl. Acad. Sci. USA 2004, 101: 1206-10.
113. Sacco, A., Doyonnas, R., LaBarge, M.A., Hammer, M.M., Kraft, P., Blau, H.M. IGF-I increases bone marrow contribution to adult skeletal muscle and enhances the fusion of myelomonocytic precursors. J. Cell Biol. 2005, 171: 483-92.
114. Rosen, C.J., Conover, C. Growth hormone/insulin-like growth factor-I axis in aging: a summary of a National Institutes of Aging-Sponsored Symposium. J. Clin. Endocrinol. Metab. 1997, 82: 3919-22.
115. Winn, N., Paul, A., Musarò, A, Rosenthal, N. Insulin-like growth factor isoforms in skeletal muscle aging, regeneration, and disease. Cold Spring Harb. Symp. Quant. Biol. 2002, 67: 507-18.
116. Barton, E.R., Morris, L., Musarò, A., Rosenthal, N. Sweeney, H.L. Muscle specific expression of Insulin-like Growth Factor 1 counters muscle decline in mdx mice. J. Cell Biol. 2002, 157: 137-48.
117. Abmayr, S., Gregorevic, P., Allen, J.M., Chamberlain, J.S. Phenotypic improvement of dystrophic muscles by rAAV/microdystrophin vectors is augmented by Igf1 codelivery. Mol. Ther. 2005, 12: 441-50.
118. Dobrowolny, G., Giacinti, C., Pelosi, L., Nicoletti, C., Winn, N., Barberi, L., Molinaro, M., Rosenthal, N., Musarò, A. Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. J. Cell Biol. 2005, 168: 193-9.
119. Kaspar, B.K., Llado, J., Sherkat, N., Rothstein, J.D., Gage, F.H. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 2003, 301: 839-42.
120. Papadakis, M.A., Grady, D., Black, D., Tierney, M.J., Gooding, G.A., Schambelan, M., Grunfeld, C. Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann. Intern. Med. 1996, 124: 708-16.
121. Delbono, O. Regulation of excitation contraction coupling by insulin-like growth factor-1 in aging skeletal muscle. J. Nutr. Health Aging 2000, 4: 162-4.